发明名称 GAPPED OLIGOMERIC COMPOUNDS COMPRISING 5'-MODIFIED DEOXYRIBONUCLEOSIDES IN THE GAP AND USES THEREOF
摘要 The present invention provides gapped oligomeric compounds. More particularly the gapped oligomeric compounds provided herein comprise at least one modified intemucleoside linkage in the gap region. Such gapped oligomeric compounds have one or more improved properties such as selectivity, potency, improved toxicity profile and or improved proinflammatory profile. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.
申请公布号 EP2742136(A1) 申请公布日期 2014.06.18
申请号 EP20120751399 申请日期 2012.08.08
申请人 ISIS PHARMACEUTICALS, INC. 发明人 OESTERGAARD, MICHAEL;PRAKASH, THAZHA, P.;SETH, PUNIT, P.;SWAYZE, ERIC, E.
分类号 C12N15/11;A61K31/712;C12N15/113 主分类号 C12N15/11
代理机构 代理人
主权项
地址